JPRN-UMIN000028313已完成未知
A prospective comparison between liraglutide-plus-basal-insulin combined therapy and intensive insulin therapy in patients with non-insulin-dependent type2 diabetes. - A prospective comparison between liraglutide-plus-basal-insulin combined therapy and intensive insulin therapy in patients with non-insulin-dependent type2 diabetes.
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 80years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1.Patients with severe ketosis,diabetic coma,the former comatose or type 1 diabetes. 2.Patients with the serious infection,the perioperative period and the serious trauma. 3.Patients with severe renal dysfunction including the patients needing haemodialysis or peritoneal dialysis. 4.Patients with a history of hypersensitivity to liraglutide. 5.Patients with the pregnant woman or the woman who may be pregnant. 6.Patients with serious renal dysfunction,serious liver dysfunction,collagenous or a malignant tumor. 7.In addition,the patient who judged inappropriate by an attendant physician. 8.Patients who take dipeptide-peptidase4 inhibitor,sulfonylurea.
研究者
相似试验
进行中（未招募）
1 期
A comparative study of the effects of Liraglutide and Acarbose on glycaemic control, weight and Health-Related Quality-of-life(HRQOL) in Overweight type 2 Diabetic patients on Oral Hypoglycemic Agents (OHA's)+ high doses of insulin. - Liraglutide & Acarbose effect on HbA1c, Wt and HRQOL in type2 DiabetesType-2 Diabetes MellitusEUCTR2010-020193-42-GBHywel DdA Health Borad66
招募中
不适用
Comparison of efficacy of liraglutide and dulaglutide in type 2 diabetes mellitus patientsJPRN-UMIN000019070Haga Diabetes Clinic75
招募中
不适用
Comparison of Liraglutide vs. Dulaglutide in type 2 diabetic outpatients using Flash Glucose monitoring (FGM)JPRN-UMIN000030624Kitasato University School of Pharmacy60
已完成
3 期
The effect of liraglutide versus placebo when added to basal insulin analogues with or without metformin in subjects with type 2 diabetes A 26-week double-blind placebo-controlled randomised multicentre, multinational parallel-group trial10018424diabetesdiabetes mellitusNL-OMON37485ovo Nordisk30
进行中（未招募）
不适用
The effect of liraglutide versus placebo when added to basal insulin analogues with or without metformin in subjects with type 2 diabetesDiabetes Mellitus, Type 2MedDRA version: 14.1Level: LLTClassification code 10045242Term: Type II diabetes mellitusSystem Organ Class: 10027433 - Metabolism and nutrition disordersEUCTR2011-002696-41-FIovo Nordisk A/S446